Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof

Details for Australian Patent Application No. 2010209650 (hide)

Owner Lek Pharmaceuticals d.d.

Inventors Casar, Zdenko; Kosmrlj, Janez

Agent Griffith Hack

Pub. Number AU-A-2010209650

PCT Pub. Number WO2010/086438

Priority 09151881.1 02.02.09 EP

Filing date 1 February 2010

Wipo publication date 5 August 2010

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/086438 Priority application(s): WO2010/086438

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010209655-Solar absorber module and solar absorber arrangement

2010209649-Herbicidal compositions comprising naptalam